RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Augustine Therapeutics

Augustine Therapeutics

Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases.

Latest funding

$85M Series A ·

Led by Jeito Capital · Source: fundraisingfox.com

Total raised: $103.17M across 2 sourced rounds

All 2 rounds ↓
Website: augustinetx.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Pharmaceutical.
Stage: Series A.
Based in: Leuven, Belgium.
Total raised: $103.17M in 2 sourced rounds.
Last round: Mar 24, 2025 · 602 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredDec 12, 2019 (6 years old)
About Augustine Therapeutics

Discover our pipeline poised for clinical impact.

Funding rounds

DateRoundAmountLeadSource
Series A$85MJJeito Capitalfundraisingfox.com
Series A$18.17MAAsabys Partnersfundraisingfox.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Augustine Therapeutics

Other companies backed by Jeito Capital

Jeito Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/augustine-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy